Response to Anti-Fraud Task Force Interim Report, July 2012

Similar documents
Automobile Insurance Market Conduct Assessment Report. Part 1: Statutory Accident Benefits Schedule Part 2: Rating and Underwriting Process

Service Providers 2014 Compliance Report March 2016

ONTARIO TRIAL LAWYERS ASSOCIATION. OTLA s Submission to the College of Physicians and Surgeons of Ontario (CPSO) Draft Transparency Principles

Response to: Ontario Automobile Anti-Fraud Task Force Steering Committee Status Update. Submitted by:

INSURANCE LAW BULLETIN

Are you prepared for changes to the Ontario Automobile Insurance Legislation?

Service Provider Information Session Your Licensing Questions Answered. Windsor, Ontario October 15, 2014

8 Professional Conduct and Disciplinary Policy for the LEED for Homes Program

Chapter 13 Section 6. Provider Exclusions, Suspensions, And Terminations

REPORT OF THE OFFICE OF THE INSPECTOR GENERAL

REPORT TO THE NATIONS ON OCCUPATIONAL FRAUD AND ABUSE 2016 SOUTHERN ASIA EDITION

Fraud, Waste and Abuse: Compliance Program. Section 4: National Provider Network Handbook

Code of Conduct. This Code of Conduct covers all associates. When appropriate, it also covers all members of the Company's Board of Directors.

TENANCY FRAUD POLICY. Executive Summary. This document outlines our policy on how Orbit as a business approaches and manages Tenancy Fraud.

Compliance Program. Health First Health Plans Medicare Parts C & D Training

Request for Qualifications. Change Management Lead. Texas FAIR Plan Association

Guide to Completing Your Membership Renewal

Title: Anti-Bribery Policy

SECOND CONSULTATION ON FIT AND PROPER TEST. February 2006 CONSULTATION PAPER CP15 1

IN THE MATTER OF THE INSURANCE ACT, R.S.N.B. Chap. I-12. -and- IN THE MATTER OF. DEAN J.E. FLETCHER (of Harvey Insurance Limited)

Amgen GLOBAL CORPORATE COMPLIANCE POLICY

CODE OF ETHICS. for. Hennessy Funds Trust and Hennessy Advisors, Inc. Code of Ethics. June 2017

Ridgecrest Regional Hospital Compliance Manual

30 Eglinton Avenue West, Suite 740 Mississauga ON L5R 3E ; April 16, Ontario Ministry of Finance

Region 10 PIHP FY Corporate Compliance Program Plan

CONTRACTOR PREQUALIFICATION FORM Submit to

UPDATE ON CHANGES TO ONTARIO AUTOMOBILE LEGISLATION (2014 and beyond)

CHUBB WORKPLACE BENEFITS A BUSINESS UNIT OF COMBINED INSURANCE COMPANY OF AMERICA, A CHUBB COMPANY INSTRUCTIONS FOR FILING CLAIMS

Re: Consultation Regulation of Financial Planners

Operational Policy General Treatment Provider Recognition

NEW YORK STATE VENDOR RESPONSIBILITY QUESTIONNAIRE FOR-PROFIT CONSTRUCTION (CCA-2)

Response to the Department for Business, Innovation and Skills discussion paper. The register of people with significant control (PSC register):

1) The Act or the Community Association Managers Practice Act means , et seq., C.R.S.

IBM Watson Care Manager Cloud Service

Outline of the System Reform Concerning. the Utilization of Personal Data

Charging, Coding and Billing Compliance

DECISION ON A PRELIMINARY ISSUE

COMPLIANCE TRAINING 2015 C O M P L I A N C E P R O G R A M - F W A - H I P A A - C O D E O F C O N D U C T

GMR INFRASTRUCTURE LIMITED

For over a decade, the Office of Inspector General

Title CIHI Submission: 2014 Prescribed Entity Review

Anti-Corruption Law in Vietnam Foreign Corrupt Practices Act

Anti-fraud and Corruption Policy

Policies and Procedures. Code of Ethics Policy

Technical Rules: Exposure Draft and Interim Guidance for the Performance of Assurance Work on Benchmarks and Indices

Effective Date: 9/09

EXPERIENCE AND QUALIFICATION STATEMENT OF

PERSHING RESOURCES COMPANY CODE OF ETHICS AND BUSINESS CONDUCT. Adopted as of April 9th, 2018

MORTGAGE BROKERAGES, MORTGAGE LENDERS AND MORTGAGE ADMINISTRATORS ACT. A Consultation Draft

Company Accreditation

AMATEUR SPORTS ASSOCIATION INSURANCE APPLICATION

Wholesale Originations Best Practices

The University has no tolerance of bribery and fraud and will take appropriate action to prevent it in respect of its activities.

13. JUSTICE - ALTERNATIVE DISPUTE RESOLUTION PROGRAM FOR COMPENSATION OF VICTIMS OF ABUSE AT PROVINCIAL YOUTH INSTITUTIONS

Understanding and Effectively Negotiating Contracts

The Voice of the Legal Profession

INSURANCE AGENTS AND BROKERS PROFESSIONAL LIABILITY APPLICATION

SANCTION SCREENING: OIG HIGH RISK PRIORITY

Florida Senate SB 1106

Risk Oversight Committee

Power Source SM New Business Application (for private companies with more than 250 employees)

Reasonable Compliance Needed

Whistle-Blowing Policy

Ontario Student Assistance Program

CMS Part D UPDATES. Kim Brandt Director, Program Integrity Centers for Medicare & Medicaid Services

54TH LEGISLATURE - STATE OF NEW MEXICO - FIRST SESSION, 2019

FINAL NOTICE The FSA gave you a Decision Notice on 28 July 2010 which notified you that the FSA had decided to:

Middlebury College Identity Theft Prevention Program

WHISTLE BLOWER POLICY

Regulatory Notice 11-06

Legal Aid Review. What We Heard: A Summary of Consultation Input. Version 1.1 (May 8, 2017)

STRATEGY FOR THE SUPERVISION AND INSPECTION OF GAMING IN SPAIN

For faster claim payment* please submit your claim online at

Withholding and Reporting Requirements

HALIFAX REGIONAL WATER COMMISSION PROCUREMENT POLICY. Edited May 22, 2012

OCF - 3 THE DISABILITY CERTIFICATE USER MANUAL

AMENDED ANTI-FRAUD PLAN FOR AVMED, INC. Amended November 2014

30.17 Identity Theft Protection Policy October 2018

VENTURE CAPITAL & PRIVATE EQUITY FUNDS

Fraud and Error Penalties and Sanctions. Equality impact assessment March 2011

This document sets out the University s position on Fraud and Bribery and its framework for addressing the Bribery Act Scope

SIU s Role 10/18/2012. Earl D. Bock, BS, AHFI Director - Highmark Financial Investigations and Provider Review

CODE OF BUSINESS CONDUCT AND ETHICS

AC 3290-S (Rev. 9/13) NEW YORK STATE VENDOR RESPONSIBILITY QUESTIONNAIRE FOR-PROFIT BUSINESS ENTITY

April 2015 FC 158/12 E. Hundred and Fifty-eighth Session. Rome, May Anti-Fraud and Anti-Corruption Policy

ELEMENTS FOR THE CONTROL OF PHARMACEUTICAL PRODUCTS CONTAINING NARCOTICS AND PSYCHOACTIVE SUBSTANCES

BOLSAS Y MERCADOS ESPAÑOLES, SISTEMAS DE NEGOCIACIÓN, S.A. ALTERNATIVE EQUITY MARKET GENERAL REGULATIONS

WHISTLE BLOWER POLICY

Consent for Services and Financial Policy

CHAPTER 20 - MANAGED CARE HEALTH BENEFIT PLANS SECTION MANAGED CARE DEFINITIONS

Trends in California s Workers Compensation System. Christine Baker Department of Industrial Relations April 2017

Figure 1: Status of Actions Recommended in November 2015 Committee Report

Administrative Monetary Penalties

POSIT MTF Participant Manual

LTD EMPLOYER'S STATEMENT

Standards of Practice Practice-Specific Standards for Pension Plans

False Claims Prevention

Reflections. Introduction. Public Accounts and Ontario s Growing Debt Burden. Bonnie Lysyk Auditor General of Ontario

Authored and prepared by egx

OCF 23 THE PRE-APPROVED FRAMEWORK TREATMENT CONFIRMATION FORM USER MANUAL

Transcription:

Response to Anti-Fraud Task Force Interim Report, July 2012 August 16, 2012 We have reviewed the proposed Regulatory Model for Healthcare and Assessment Facilities in Ontario, prepared by Mr. Willie Handler on July 19, 2012, as well as the analysis and comments prepared by the Anti-Fraud Task Force in their recent report. The Alliance supports the spirit and principles behind a regulatory system whose goal is to prevent, detect and punish fraudulent behaviour. We are therefore in agreement with Mr. Handler s and the Anti -Fraud Task Force s recommended objectives in instituting a regulatory model: Transparency in ownership, costs and conflicts of interest Accountability for facilities, owners and practitioners Verification of practices Sanctions for fraudulent behaviour We are also strongly in support of active collaboration between a new regulatory entity focused on fraud and the existing College system focused on clinical practices. Finally, we agree that all private facilities should be covered under the same umbrella, whether providing assessment and treatment at the client s request or assessments at the insurer s request, whether small or large, and whether comprised of regulated or unregulated providers. We do note, however, that fraudulent billing to government and insurers is not limited to the auto insurance sector and have therefore factored that into our commentary. Who Would Be the Regulator? Mr. Handler has recommended that this function be filled by FSCO. We believe, however, that there would be considerable value in involving other public sector entities such as the Ministry of Health, OHIP, the Ministry of Community and Social Services, the Ministry of Education, Veterans Affairs Canada, and the Workplace Safety and Insurance Board, some of which were referenced in the recent Anti- Fraud Task Force report. We also believe that insurers who provide extended health insurance coverage would be interested in participating (indeed, they offered a seminar via the regulatory Colleges earlier this year on the topic of fraud in the private health sector). Given that the government s emphasis is on eliminating fraud by health care providers (versus other suppliers to the the insurance system where fraud can occur) and the fact that fraud is occurring in numerous other sectors beyond just auto, we believe that anti-fraud regulation should be a joint responsibility shared between FSCO and the Ministry of Health (via the existing regulatory College system). This would better reflect the emphasis on health care providers and that the particular 3 rd party payer who may be at risk due to fraud crosses a range of jurisdictions beyond just FSCO.

In addition to the regulatory body itself being established jointly by Health and Finance, we believe that a multi-stakeholder advisory board will be crucial to this venture s success. It is our opinion that a large part of the efficacy of the Anti- Fraud Task Force has been related to the synergies resulting from various Ministries, Departments and key stakeholders sharing information. Bringing this diversity of knowledge and experience together is a critical success factor for the Anti- Fraud Task Force and we believe would be equally so in the development of an effective regulatory entity. We note that some consideration to the involvement of the Ministry of Consumer and Commercial Relations may be warranted, given their work on consumer-level fraud in the province. In the regulatory College system, a proportion of each College s Board is comprised of representatives of the frontline individuals who are being regulated. This is an important aspect of ensuring the College is in tune with frontline service provision issues. We therefore strongly recommend that frontline providers in the auto sector be included in FSCO s regulatory entity via the advisory board concept. Given that the Alliance is the only multi-disciplinary association comprised of only frontline providers who work directly in the system, we would be pleased to assume this role in the regulatory entity. While the initial work completed by this entity would be focused on the auto sector given the current emphasis in this area, we believe it could then be organically extended to other health care environments where funding is provided on a 3 rd party basis. The auto sector could be the pilot project for broader anti-fraud regulation of all private health practices in Ontario. Categories of Licenses Mr. Handler has suggested three categories of licensing related to volume of billing in the auto sector and the regulated or unregulated nature of work being conducted. While we believe that such a division is essentially arbitrary, we are not opposed to it. It is our understanding that the Restricted License would refer to a restriction placed on the facility to only provide services in the specific license category applied for. Mr. Handler provided some examples of such service categories. We know this is simply a list of examples, but we wish to ensure that several other important providers of unregulated goods and services would be covered, notably rehabilitation support workers, personal support workers and equipment vendors. We will support a Restricted License category if it includes all unregulated providers. We support that such facilities would still be required to have a Clinical Director role, but the role would not necessarily be filled by a regulated health professional. Sole practitioners in any license category would themselves fill the role of Clinical Director. License Application Process We recommend that all facilities, regardless of license category, follow the same application process, which would include submission of: Facility basic information (e.g., name, operating address(es) and other contact information, year operations began, prior operating name(s) if they have changed) Overview of services to be provided Ownership structure (e.g., sole proprietor, partnership, incorporation)

Articles of incorporation (if applicable) List of related healthcare companies (through common shareholder ownership) Personal shareholder information (for non-publicly traded entities) including names, addresses and attestation regarding any past felony conviction in any jurisdiction Consent for background check on owners and management in any jurisdiction Attestation that facility will comply with regulator s requests to verify invoices Statutory declaration of no conflicts of interest with respect to ownership and services provided (e.g., an insurer, adjusting company or lawyer/paralegal cannot own a health facility) Name(s) and resume(s) of Clinical Director(s) with prerequisite minimum 5 years experience, with no Clinical Director having had a felony conviction or license revocation in the past 5 years in any jurisdiction Clinical Director must attest to being on-site for a minimum of 50% of the facility s operating hours (recognizing that this time may be divided across more than one site if the company operates at more than one location or time is split between clinic/office and client locations in the community) Clinical Director must attest to having unrestricted access to the company s financial information For companies providing Insurer Examinations, Clinical Director must attest that all assessors have a minimum set of qualifications, including at least 5 years experience in the specific area(s) they assess We note that Mr. Handler made recommendations for the Clinical Director to be a bank account signatory. We do not believe that this requirement will have any impact on the ability to perpetrate fraud given how easily it can be manipulated. We therefore recommended requiring the Clinical Director to have unrestricted access to the company s financial information as we believe this is the more crucial element. Mr. Handler also made note of liability policies, however there are no signatories on liability policies, these policies are simply purchased for individuals and corporations. License Issuing Process Mr. Handler has suggested that applications must meet a fit and proper test. It is unclear to us what this means and until this is clarified, we object to it. It is our recommendation that licensing should be subject to proper application as outlined above. Licensing should be a process based on meeting clearly stated requirements that are not subject to interpretation. Any facilities currently operating in the system who demonstrate adherence to the application requirements set out above should be issued licenses. If a document exists which describes the fit and proper test, we would like to review it and have opportunity to provide commentary. License Renewal Process Facilities will complete and submit an Annual Information Return where they supply descriptions of how they ensured compliance with the various requirements noted in the application process above. We note that Mr. Handler additionally recommended quarterly attestations regarding accuracy and

appropriateness of bills submitted through HCAI. We believe that this is an unnecessary and nonbeneficial requirement, given the other recommendations made. Mr. Handler has suggested that facilities must notify the regulator of a change in Clinical Directors within 15 days. Knowing the complexities that often occur with a change in staff, we believe that 30 days is a more reasonable expectation without putting insurers at undue risk. We also believe that a similar notification should be provided if there is any substantive change in the licensing information (e.g., ownership, business name and address, etc.). Monitoring, Investigation & Sanction Processes We believe that considerable work needs to go into developing these systems and that the existing Colleges are best able to provide guidance into how to structure them. The Alliance would be happy to participate in discussions to this end, as we uniquely bring the frontline provider and health practice owner perspective to the table. Considerations for the risk- and complaints-based investigation process should include the following requirements: Complainant must submit evidence of a pattern of behavior Complaint must be specific in nature and related to fraud or a pattern of abusive actions; all other complaints should be referred to the regulatory College Regulatory Colleges must inform FSCO when a license is revoked (recognizing that a clinical restriction in practicing may or may not be relevant to anti-fraud regulation, so the College should specify its reason for restricting or revoking a license) Criteria must objectively specify what level of evidence will trigger an investigation Investigations may include audits of invoices submitted to confirm with actual clients (subject to permissions granted by the regulatory Colleges), review and follow up on information provided in license application (e.g., criminal background check on an owner or manager), review with College (if applicable) if any complaints or investigations are underway there, site visits to review facilities and financial procedures in place Investigations must be respectful and limited to the anti-fraud scope of regulation Sanctions must fit the nature and severity of the infraction, ranging from a warning (e.g., for failing to inform regulator of a change in Clinical Director, billing within less than 30 days, etc.) to license suspension (e.g., when fraud is confirmed) Process for reinstatement of license must be specified Other Anti- Fraud Measures In its Interim Report, the Anti- Fraud Task Force included a number of areas for recommendation and input in addition to the implementation of a regulator for private health clinics in Ontario. We would like to offer our comments on some of these additional recommendations. In the last reforms, many UDAPs that referred to insurer behaviour were removed. We would like to see a return to a balance of accountabilities in this realm between both providers and insurers.

We support the use of Crime Stoppers as described in the Anti- Fraud Task Force report. We support the implementation of a Professional Credential Tracker system where individual providers can verify directly how their name and regulatory number is being used. We also support the recommendations to inform consumers of expected business practices. We support requiring clients to sign an attendance log any time they attend for assessment or treatment sessions. We support requiring clients to sign that they have received goods provided (e.g., orthotics, back rest, grab bar, etc.) and requiring that providers keep copies of all invoices for goods purchased on the client s behalf. We believe additional clarification is required regarding charging clients $500 if they do not show up for an insurer examination. This is a complicated issue that warrants additional discussion and we are not sure how it relates to fraudulent activity. We do not see the need for additional examinations under oath. This is a very stressful process for clients to go through and the insurer has many other ways of gathering the information they require, including via insurer examinations and simple requests for information. We do not support the blanket civil immunity proposal. Insurers need to be held accountable for their behaviour, just as all other stakeholders are held accountable. Insurers already regularly accuse many legitimately seriously injured clients of being malingerers. If civil immunity is given, we are concerned there may be additional abuse of this power which will result in serious hardship for victims. We support referencing the Cost of Goods Guideline in the SABS. We support prohibiting clients from signing blank OCF forms by making this act an unfair and deceptive act or practice. We support requiring insurers to provide an itemized breakdown of specific expenses incurred every 2 months. We support insurers having to disclose information pertaining to preferred providers and their claims management processes to help consumers make informed choices of carrier beyond just price. However, we do not see this as an anti-fraud measure. In conclusion, we see benefits to clients and the system as a whole in much of what Mr. Handler has proposed. However, we believe that consideration of our recommendations will further enhance the benefits and make for a system that best reflects the needs and realities of this sector and the health care system in general.